ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $621,000 | -15.7% | 151,406 | -26.7% | 0.00% | – |
| Q4 2021 | $737,000 | -69.5% | 206,517 | -68.9% | 0.00% | -100.0% |
| Q3 2021 | $2,415,000 | +0.5% | 663,427 | +20.5% | 0.00% | 0.0% |
| Q2 2021 | $2,402,000 | +72.8% | 550,708 | +62.8% | 0.00% | – |
| Q1 2021 | $1,390,000 | -19.5% | 338,303 | -21.8% | 0.00% | – |
| Q4 2020 | $1,726,000 | +67.1% | 432,378 | +13.1% | 0.00% | – |
| Q3 2020 | $1,033,000 | -5.5% | 382,404 | -3.8% | 0.00% | – |
| Q2 2020 | $1,093,000 | +52.4% | 397,423 | +30.6% | 0.00% | – |
| Q1 2020 | $717,000 | -14.7% | 304,328 | +70.1% | 0.00% | – |
| Q4 2019 | $841,000 | +198.2% | 178,888 | +112.0% | 0.00% | – |
| Q3 2019 | $282,000 | -57.5% | 84,389 | -58.2% | 0.00% | – |
| Q2 2019 | $664,000 | -14.5% | 201,896 | -21.2% | 0.00% | – |
| Q1 2019 | $777,000 | +20.7% | 256,308 | +8.4% | 0.00% | – |
| Q4 2018 | $644,000 | +122.8% | 236,419 | +175.0% | 0.00% | – |
| Q3 2018 | $289,000 | -94.4% | 85,969 | -95.7% | 0.00% | -100.0% |
| Q2 2018 | $5,152,000 | +21.1% | 1,996,921 | +3.3% | 0.00% | +100.0% |
| Q1 2018 | $4,253,000 | +34.2% | 1,933,469 | +21.5% | 0.00% | 0.0% |
| Q4 2017 | $3,168,000 | -26.8% | 1,591,407 | +19.1% | 0.00% | 0.0% |
| Q3 2017 | $4,328,000 | +29.1% | 1,335,906 | +28.3% | 0.00% | 0.0% |
| Q2 2017 | $3,352,000 | +53.8% | 1,041,096 | +35.6% | 0.00% | 0.0% |
| Q1 2017 | $2,180,000 | +48.3% | 767,600 | +21.6% | 0.00% | 0.0% |
| Q4 2016 | $1,470,000 | +114.0% | 631,000 | +54.3% | 0.00% | – |
| Q3 2016 | $687,000 | +86.2% | 409,000 | +16.4% | 0.00% | – |
| Q2 2016 | $369,000 | +109.7% | 351,500 | +72.5% | 0.00% | – |
| Q1 2016 | $176,000 | -24.8% | 203,738 | +5.3% | 0.00% | – |
| Q4 2015 | $234,000 | -34.1% | 193,416 | -7.4% | 0.00% | – |
| Q3 2015 | $355,000 | -35.8% | 208,875 | -21.4% | 0.00% | – |
| Q2 2015 | $553,000 | -46.5% | 265,859 | -30.4% | 0.00% | – |
| Q1 2015 | $1,034,000 | +161.1% | 381,824 | +148.1% | 0.00% | – |
| Q4 2014 | $396,000 | +59.0% | 153,915 | +13.3% | 0.00% | – |
| Q3 2014 | $249,000 | -42.8% | 135,872 | -16.5% | 0.00% | – |
| Q2 2014 | $435,000 | -17.9% | 162,806 | +7.5% | 0.00% | – |
| Q1 2014 | $530,000 | -21.7% | 151,500 | 0.0% | 0.00% | – |
| Q4 2013 | $677,000 | +24.9% | 151,500 | +13.5% | 0.00% | – |
| Q3 2013 | $542,000 | -0.9% | 133,500 | +1.5% | 0.00% | – |
| Q2 2013 | $547,000 | – | 131,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |